ATE319090T1 - Verwendung eines papillarfibroblast-spezifischen antikörpers als marker der hautqualität - Google Patents

Verwendung eines papillarfibroblast-spezifischen antikörpers als marker der hautqualität

Info

Publication number
ATE319090T1
ATE319090T1 AT00403310T AT00403310T ATE319090T1 AT E319090 T1 ATE319090 T1 AT E319090T1 AT 00403310 T AT00403310 T AT 00403310T AT 00403310 T AT00403310 T AT 00403310T AT E319090 T1 ATE319090 T1 AT E319090T1
Authority
AT
Austria
Prior art keywords
skin
marker
specific antibody
skin quality
papillary
Prior art date
Application number
AT00403310T
Other languages
English (en)
Inventor
Daniel Asselineau
Arnold Caplan
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE319090T1 publication Critical patent/ATE319090T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/971—Capture of complex after antigen-antibody reaction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
AT00403310T 1999-12-03 2000-12-04 Verwendung eines papillarfibroblast-spezifischen antikörpers als marker der hautqualität ATE319090T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9915292A FR2801979B1 (fr) 1999-12-03 1999-12-03 Utilisation d'un anticorps specifique des fibroblastes papillaires comme marqueur de qualite d'une peau

Publications (1)

Publication Number Publication Date
ATE319090T1 true ATE319090T1 (de) 2006-03-15

Family

ID=9552884

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00403310T ATE319090T1 (de) 1999-12-03 2000-12-04 Verwendung eines papillarfibroblast-spezifischen antikörpers als marker der hautqualität

Country Status (8)

Country Link
US (2) US20010036642A1 (de)
EP (1) EP1111389B1 (de)
JP (1) JP3516263B2 (de)
AT (1) ATE319090T1 (de)
CA (1) CA2326713C (de)
DE (1) DE60026272T2 (de)
ES (1) ES2259599T3 (de)
FR (1) FR2801979B1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9969980B2 (en) * 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
US9969977B2 (en) * 2002-09-20 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
US8354370B2 (en) * 2007-06-15 2013-01-15 Garnet Biotherapeutics, Inc. Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders
EP2783212B1 (de) * 2011-11-25 2016-10-05 Chanel Parfums Beauté Neuartige marker für papilläre und retikuläre fibroblasten sowie verwendungen dafür
GB201721738D0 (en) * 2017-12-22 2018-02-07 King S College London Method

Also Published As

Publication number Publication date
US20010036642A1 (en) 2001-11-01
FR2801979B1 (fr) 2002-02-08
DE60026272T2 (de) 2006-11-23
DE60026272D1 (de) 2006-04-27
EP1111389A1 (de) 2001-06-27
JP2001215225A (ja) 2001-08-10
CA2326713A1 (fr) 2001-06-03
ES2259599T3 (es) 2006-10-16
US20040082016A1 (en) 2004-04-29
FR2801979A1 (fr) 2001-06-08
EP1111389B1 (de) 2006-03-01
US7192719B2 (en) 2007-03-20
CA2326713C (fr) 2007-01-02
JP3516263B2 (ja) 2004-04-05

Similar Documents

Publication Publication Date Title
DE69836332D1 (de) Benzyliden-1,3-dihydro-indol-2-on-derivate als inhibitoren von rezeptor tyrosine kinasesn, insbesondere von raf kinasen
Schieker et al. Human mesenchymal stem cells at the single‐cell level: simultaneous seven‐colour immunofluorescence
ATE410998T1 (de) Verwendung einer proteinkinase a-inaktivierenden verbindung in einer kosmetisch verträglichen zusammensetzung zur aufhellung der haut
DE59709027D1 (de) Verwendung von polymerisatdispersionen als bindemittel für dichtungs- oder beschichtungsmassen
DK0845963T3 (da) Anvendelse af autologe dermale fibroblaster til reparation af hud- og blødvævsdefekter
DE60122337D1 (de) Verwendung von taci als antitumormittel
ES2124793T3 (es) Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores.
DE69011329D1 (de) Pdgf-alpha-rezeptor.
ES2148353T3 (es) Ensayo para la determinacion de proteina en una muestra biologica.
Sillman et al. Human dermal fibroblasts do not exhibit directional migration on collagen I in direct‐current electric fields of physiological strength
Schwarz et al. Ascorbate induction of collagen synthesis as a means for elucidating a mechanism of quantitative control of tissue-specific function
DE50012617D1 (de) Verwendung von methylchinolinium-verbindungen zum färben von keratinhaltigen fasern
ATE166532T1 (de) Anatomisches und biologisches konservierungsmittel und verbesserte einbalsamierungszusammensetzung und -verfahren
DE60107416D1 (de) Adnf mischungen zur verbesserung der lernfähigkeit und der gedächtnisfunktion
DE60026272D1 (de) Verwendung eines Papillarfibroblast-spezifischen Antikörpers als Marker der Hautqualität
BR9406223A (pt) Método para determinar em uma amostra a atividade funcional de um componente da coagulação sanguinea método para diagnosticar um disturbio da coagulação/anticoagulação sanguinea preparado de anticorpo linhagem celular uso de fator v subunidades ou fragmentos do mesmo tendo atividade anticoagulante na forma de cofator par apc prepraro de plasma embalado plasma deficiente em atividade anticoagulante de fator v como cofator para apc uso do preparado de anticorpo preparado de proteina s preparado de
ATE520024T1 (de) Patch-clamp-verfahren und seine verwendung zur untersuchung subzellulärer merkmale
MX9602557A (es) Proteinas de higado de mamifero y su uso en oncologia.
ATE280836T1 (de) Test zur gleichzeitigen messung von verschiedenen enzymatischen aktivitäten
ATE277352T1 (de) Einetenascin-c isoform als marker für neoplasmen
DE60003038D1 (de) Chemokin bindendes protein von gammaherpesvirus 68 und verfahren zu seiner verwendung
DE69229230D1 (de) Antikörpertest zur erkennung von alkoholikern und zur überwachung der alkoholaufnahme
ATE353338T1 (de) Synthetische biepitopische zusammensetzungen zur verwendung als kalibratoren bei der biologischen bestimmung von troponin i
WO2001094550A3 (en) Identification and use of molecular markers indicating cellular reprogramming
DE60035424D1 (de) Neue enzyme und metabolite im skatol-stoffwechsel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties